“C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells”. Journal of Analytical Oncology 2, no. 4 (December 28, 2013): 195–208. Accessed June 28, 2026. https://neoplasiaresearch.com/index.php/jao/article/view/87.